Bright Minds Biosciences ... (DRUG)
NASDAQ: DRUG
· Real-Time Price · USD
52.35
1.37 (2.69%)
At close: Sep 25, 2025, 3:59 PM
52.35
0.00%
After-hours: Sep 25, 2025, 04:47 PM EDT
2.69% (1D)
Bid | 49.37 |
Market Cap | 370.9M |
Revenue (ttm) | n/a |
Net Income (ttm) | -8.89M |
EPS (ttm) | -0.99 |
PE Ratio (ttm) | -52.88 |
Forward PE | -9.75 |
Analyst | Buy |
Dividends | n/a |
Ask | 53 |
Volume | 108,948 |
Avg. Volume (20D) | 72,266 |
Open | 50.00 |
Previous Close | 50.98 |
Day's Range | 48.90 - 52.37 |
52-Week Range | 0.94 - 79.02 |
Beta | -0.14 |
Ex-Dividend Date | n/a |
About DRUG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DRUG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DRUG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+3.36%
Shares of psychedelic companies are trading higher...
Unlock content with
Pro Subscription
10 months ago
-1.24%
Bright Minds Biosciences shares are trading higher after Baird initiated coverage on the stock with an Outperform rating and announced a price target of $75.